|Access to this symposium is free, but to take the post-test you must first be a
registered FREE ZONE user of HDCN. The CE credits provided by ANNA require a fee, as detailed at this link.
If not already an HDCN FREE ZONE user, please
register at this link and select a username and password.
|| (Keynote Address:) Focus on the
Challenges, Solutions -
Brigadier General Barbara C. Brannon, MSN, BSN,
(Keynote Address): Focus on
Future: Realities, Challenges,
Solutions - Part Two
Brigadier General Barbara C. Brannon, MSN, BSN, CNAA
Activity goal: Please see individual talks.
Barbara C. Brannon, MSN, BSN, CNAA
Commander, 89 Medical Group
AF Deputy Surgeon General
Nursing Services, USAF
Each talk, depending on its length, is acredited
by the American Nephrology Nurses' Association (ANNA)
|| Date of Original Release: See individual talks
CE Credit Eligible Through: See individual talks
Contact Hours/Completion Time: See individual talks
Target Audiences: Nephrology nurses and technicians.
Method of participation: Listen to the talk, read the PubMed
abstracts linked to data slides and talk references, take the posttest, read
the linked abstracts in the posttest, answer feedback material.
Chronic kidney disease affects 30-40 million Americans, of whom
several hundred thousand require renal replacement therapy. These
will allow nephrology nurses, pharmacists, and technicians to obtain
up-to-date information about issues related to care of renal patients.
This offering for 1.5 contact hours is being provided by the American
Nephrology Nurses Association (ANNA), which is accredited as a provider
and approver of continuing education in nursing by the American Nurses
Credentialing Center-Commission on Accreditation (ANCCCOA). This
educational activity is approved by most states and specialty
organizations that recognize the ANCC-COA accreditation process. ANNA is
an approved provider of continuing education in nursing by the California
Board of Registered Nursing, BRN Provider No. 00910; and the Kansas State
Board of Nursing, Provider No. LT0148-0738. This offering is accepted for
RN and LPN relicensure in Kansas.
The American Nephrology Nurses' Association, as well as HDCN have conflict of
interest policies that require course faculty to disclose
any real or apparent commercial financial affiliations related to the
content of their presentations/materials. It is not assumed that these
financial interests or affiliations will have an adverse
impact on faculty presentations; they are simply noted here to fully inform
FACULTY DISCLOSURE STATEMENTS
B. G. Brannon discloses no conflict of interest.
educational activity may contain discussion of published
investigational uses of agents that are not indicated by
The American Nephrology Nurses' Association, and HDCN do not
recommend the use of any agent outside of the labeled
Please refer to the official prescribing information for
product for discussion of approved indications,
DISCLOSURE OF UNLABELED USE:
have an implied responsibility to use the newly acquired
to enhance patient outcomes and their own professional
The information presented in this activity is not meant
to serve as a guideline for patient management. Any procedures,
medications, or other courses of diagnosis or treatment
discussed or suggested in this activity should not be used by clinicians
without evaluation of their patients' conditions and possible
on dangers in use, review of any applicable manufacturer's product
information, and comparison with recommendations of other authorities.